TAYLOR BEAIRD: Open Payments
NPI 1063956050 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,959 in 101 payments from 15 companies in 2025. Trend: 2023 $1,094 · 2024 $1,309 · 2025 $1,959
Food & beverage: $1,959
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $395 |
| Novo Nordisk Inc | 15 | $301 |
| ABBVIE INC. | 12 | $195 |
| Amgen Inc. | 16 | $187 |
| GlaxoSmithKline, LLC. | 14 | $163 |
| PFIZER INC. | 8 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $137 |
| Abbott Laboratories | 5 | $94 |
| Exact Sciences Corporation | 5 | $91 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
Products named: AIRSUPRA, Ozempic, Kerendia, TRELEGY ELLIPTA, QULIPTA, OTEZLA, FREESTYLE LIBRE 3, Cologuard Collection Kit.
Industry payments across OK — which companies pay providers there.
